Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernesto Bosch

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 7, 2012
Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cyclesElena Labarta, Ernesto Bosch, Pilar Alamá, et al.
Fertility and Sterility|November 9, 2005
Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcomeErnesto Bosch, Ernesto Escudero, Juana Crespo, et al.
Reproductive Biomedicine Online|March 14, 2024
Luteal phase support using micronized vaginal progesterone as pessaries or capsules in artificial cycles: is there any difference?Elena Labarta, Cristina Rodríguez-Varela, Maria Salvaleda-Mateu, et al.
Reproductive Biomedicine Online|December 21, 2024
Machine learning tool for predicting mature oocyte yield and trigger day from start of stimulation: towards personalized treatmentAkhil Garg, Jose Bellver, Ernesto Bosch, et al.
Human Reproduction (Oxford, England)|December 1, 2023
Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trialErnesto Bosch, Pilar Alamá, Josep Lluis Romero, et al.
Journal of Assisted Reproduction and Genetics|April 14, 2021
Minimal ovarian stimulation is an alternative to conventional protocols for older women according to Poseidon's stratification: a retrospective multicenter cohort studyMauro Cozzolino, Gustavo Nardini Cecchino, Ernesto Bosch, et al.
Fertility and Sterility|July 5, 2006
Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized studyMaría-José Escribá, José Bellver, Ernesto Bosch, et al.
Fertility and Sterility|April 5, 2021
Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trialJuan Giles, Pilar Alama, Pilar Gamiz, et al.
Reproductive Biomedicine Online|December 20, 2021
Early detection of pregnancy after IVF and embryo transfer with hyperglycosylated HCG versus Elecsys HCG+β assayErnesto Bosch, Martin Hund, Reinhard van der Does, et al.
Fertility and Sterility|December 12, 2003
Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcomeErnesto Bosch, Iván Valencia, Ernesto Escudero, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|August 7, 2012
Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cyclesElena Labarta, Ernesto Bosch, Pilar Alamá, et al.
Fertility and Sterility|November 9, 2005
Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcomeErnesto Bosch, Ernesto Escudero, Juana Crespo, et al.
Reproductive Biomedicine Online|March 14, 2024
Luteal phase support using micronized vaginal progesterone as pessaries or capsules in artificial cycles: is there any difference?Elena Labarta, Cristina Rodríguez-Varela, Maria Salvaleda-Mateu, et al.
Reproductive Biomedicine Online|December 21, 2024
Machine learning tool for predicting mature oocyte yield and trigger day from start of stimulation: towards personalized treatmentAkhil Garg, Jose Bellver, Ernesto Bosch, et al.
Human Reproduction (Oxford, England)|December 1, 2023
Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trialErnesto Bosch, Pilar Alamá, Josep Lluis Romero, et al.
Journal of Assisted Reproduction and Genetics|April 14, 2021
Minimal ovarian stimulation is an alternative to conventional protocols for older women according to Poseidon's stratification: a retrospective multicenter cohort studyMauro Cozzolino, Gustavo Nardini Cecchino, Ernesto Bosch, et al.
Fertility and Sterility|July 5, 2006
Delaying the initiation of progesterone supplementation until the day of fertilization does not compromise cycle outcome in patients receiving donated oocytes: a randomized studyMaría-José Escribá, José Bellver, Ernesto Bosch, et al.
Fertility and Sterility|April 5, 2021
Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trialJuan Giles, Pilar Alama, Pilar Gamiz, et al.
Reproductive Biomedicine Online|December 20, 2021
Early detection of pregnancy after IVF and embryo transfer with hyperglycosylated HCG versus Elecsys HCG+β assayErnesto Bosch, Martin Hund, Reinhard van der Does, et al.
Fertility and Sterility|December 12, 2003
Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcomeErnesto Bosch, Iván Valencia, Ernesto Escudero, et al.
Pageof 8